1651 related articles for article (PubMed ID: 20546737)
21. Enteroendocrine-derived glucagon-like peptide-2 controls intestinal amino acid transport.
Lee J; Koehler J; Yusta B; Bahrami J; Matthews D; Rafii M; Pencharz PB; Drucker DJ
Mol Metab; 2017 Mar; 6(3):245-255. PubMed ID: 28271031
[TBL] [Abstract][Full Text] [Related]
22. GLP-2 as Beneficial Factor in the Glucose Homeostasis in Mice Fed a High Fat Diet.
Baldassano S; Rappa F; Amato A; Cappello F; Mulè F
J Cell Physiol; 2015 Dec; 230(12):3029-36. PubMed ID: 25967277
[TBL] [Abstract][Full Text] [Related]
23. Functional GIP receptors play a major role in islet compensatory response to high fat feeding in mice.
Moffett RC; Vasu S; Flatt PR
Biochim Biophys Acta; 2015 Jun; 1850(6):1206-14. PubMed ID: 25688757
[TBL] [Abstract][Full Text] [Related]
24. Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion.
Rowland KJ; Trivedi S; Lee D; Wan K; Kulkarni RN; Holzenberger M; Brubaker PL
Gastroenterology; 2011 Dec; 141(6):2166-2175.e7. PubMed ID: 21925122
[TBL] [Abstract][Full Text] [Related]
25. A switch from prohormone convertase (PC)-2 to PC1/3 expression in transplanted alpha-cells is accompanied by differential processing of proglucagon and improved glucose homeostasis in mice.
Wideman RD; Covey SD; Webb GC; Drucker DJ; Kieffer TJ
Diabetes; 2007 Nov; 56(11):2744-52. PubMed ID: 17698597
[TBL] [Abstract][Full Text] [Related]
26. GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro.
Shao W; Wang Z; Ip W; Chiang YT; Xiong X; Chai T; Xu C; Wang Q; Jin T
Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1263-72. PubMed ID: 23571712
[TBL] [Abstract][Full Text] [Related]
27. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
Parker JC; Lavery KS; Irwin N; Green BD; Greer B; Harriott P; O'Harte FP; Gault VA; Flatt PR
J Endocrinol; 2006 Oct; 191(1):93-100. PubMed ID: 17065392
[TBL] [Abstract][Full Text] [Related]
28. Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice.
Green BD; Irwin N; Gault VA; Bailey CJ; O'Harte FP; Flatt PR
J Endocrinol; 2005 May; 185(2):307-17. PubMed ID: 15845923
[TBL] [Abstract][Full Text] [Related]
29. Expression of mRNA for proglucagon and glucagon-like peptide-2 (GLP-2) receptor in the ruminant gastrointestinal tract and the influence of energy intake.
Taylor-Edwards CC; Burrin DG; Matthews JC; McLeod KR; Holst JJ; Harmon DL
Domest Anim Endocrinol; 2010 Oct; 39(3):181-93. PubMed ID: 20688461
[TBL] [Abstract][Full Text] [Related]
30. Roles for corticotropin-releasing factor receptor type 1 in energy homeostasis in mice.
Sakamoto R; Matsubara E; Nomura M; Wang L; Kawahara Y; Yanase T; Nawata H; Takayanagi R
Metabolism; 2013 Dec; 62(12):1739-48. PubMed ID: 24054833
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of glucagon-like peptide-2 (GLP-2) is involved in pancreatic islet cell adaptations to stress and beta-cell survival.
Khan D; Vasu S; Moffett RC; Irwin N; Flatt PR
Peptides; 2017 Sep; 95():68-75. PubMed ID: 28746825
[TBL] [Abstract][Full Text] [Related]
32. Glucagon-like peptide-1 and islet lipolysis.
Sörhede Winzell M; Ahrén B
Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
[TBL] [Abstract][Full Text] [Related]
33. Beneficial effects of sub-chronic activation of glucagon-like peptide-1 (GLP-1) receptors on deterioration of glucose homeostasis and insulin secretion in aging mice.
Irwin N; McClean PL; Harriott P; Flatt PR
Exp Gerontol; 2007 Apr; 42(4):296-300. PubMed ID: 17184947
[TBL] [Abstract][Full Text] [Related]
34. Chronic administration of voglibose, an alpha-glucosidase inhibitor, increases active glucagon-like peptide-1 levels by increasing its secretion and decreasing dipeptidyl peptidase-4 activity in ob/ob mice.
Moritoh Y; Takeuchi K; Hazama M
J Pharmacol Exp Ther; 2009 May; 329(2):669-76. PubMed ID: 19208898
[TBL] [Abstract][Full Text] [Related]
35. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
Li Y; Hansotia T; Yusta B; Ris F; Halban PA; Drucker DJ
J Biol Chem; 2003 Jan; 278(1):471-8. PubMed ID: 12409292
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological targeting of glucagon and glucagon-like peptide 1 receptors has different effects on energy state and glucose homeostasis in diet-induced obese mice.
Gu W; Lloyd DJ; Chinookswong N; Komorowski R; Sivits G; Graham M; Winters KA; Yan H; Boros LG; Lindberg RA; Véniant MM
J Pharmacol Exp Ther; 2011 Jul; 338(1):70-81. PubMed ID: 21471191
[TBL] [Abstract][Full Text] [Related]
37. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia.
Conarello SL; Jiang G; Mu J; Li Z; Woods J; Zycband E; Ronan J; Liu F; Roy RS; Zhu L; Charron MJ; Zhang BB
Diabetologia; 2007 Jan; 50(1):142-50. PubMed ID: 17131145
[TBL] [Abstract][Full Text] [Related]
38. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
Tomas E; Wood JA; Stanojevic V; Habener JF
Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis.
Traub S; Meier DT; Schulze F; Dror E; Nordmann TM; Goetz N; Koch N; Dalmas E; Stawiski M; Makshana V; Thorel F; Herrera PL; Böni-Schnetzler M; Donath MY
Cell Rep; 2017 Mar; 18(13):3192-3203. PubMed ID: 28355570
[TBL] [Abstract][Full Text] [Related]
40. Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells.
Koehler JA; Harper W; Barnard M; Yusta B; Drucker DJ
Cancer Res; 2008 Oct; 68(19):7897-904. PubMed ID: 18829546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]